Breaking News Instant updates and real-time market news.

PRTA

Prothena

$56.23

2.03 (3.75%)

07:13
05/19/17
05/19
07:13
05/19/17
07:13

Prothena initiated with a Buy at BTIG

BTIG analyst Robert Hazlett initiated Prothena with a Buy and an $80 price target due to the material potential for its programs in amyloidosis, Parkinson's, and inflammatory diseases.

  • 06

    Jun

PRTA Prothena
$56.23

2.03 (3.75%)

04/12/17
PIPR
04/12/17
INITIATION
Target $69
PIPR
Overweight
Prothena initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst Steven Breazzano started Prothena with an Overweight rating and $69 price target. The analyst has a favorable view of the company's lead drug, NEOD001 for AL amyloidosis
04/12/17
CANT
04/12/17
INITIATION
Target $86
CANT
Overweight
Prothena initiated with an Overweight at Cantor
Cantor analyst William Tanner initiated Prothena with an Overweight and an $86 price target saying he views the company's intrinsic proteinmisfolding and cell-trafficking knowledge as integral to an R&D engine that could yield novel therapies to treat important diseases. Not only does Prothena have Orphan drug candidates NEOD1 and PRX004 for treating amyloidopathies, but Tanner believes the Parkinson's disease and psoriatic arthritis programs has the potential to deliver greater value.
05/16/17
RHCO
05/16/17
NO CHANGE
RHCO
Prothena has positive read through from Ionis safety issues, says SunTrust
SunTrust analyst Yun Zhong says that safety issues with Ionis' inotersen during a Phase III trial are positive for Prothena. The analyst says that Prothena's new drug, PRX004, could have a better safety profile than its previous drug, NEOD001,. He notes that PRX004 has a different mechanism of action than Ionis' drug, and he thinks the discrepancy could enable Prthena's drug to have a better safety profile. He keeps a Buy rating on Prothena.
05/16/17
PIPR
05/16/17
NO CHANGE
Target $69
PIPR
Overweight
Piper Jaffray sees positive readthrough for Prothena from Ionis data
Piper Jaffray analyst Steven Breazzano argues that investors should "take a closer look" at Prothena (PRTA) and its PRX004 product following the recent amyloid neuropathy data from Ionis Pharmaceuticals (IONS). Prothena's candidate is expected to enter the clinic in early 2018, and Breazzano argues that there is "room for differentiation" in the space, as the drug clears the protein buildup that characterizes amyloidosis rather than directly shutting off production, as with Ionis and Alnylam's (ALNY) approaches. "At a minimum," the analyst says, a deposit-clearing approach would be complementary to production-stopping drugs. Breazzano reiterates an Overweight rating on Prothena.

TODAY'S FREE FLY STORIES

CSGP

CoStar Group

$281.32

-0.65 (-0.23%)

16:36
07/26/17
07/26
16:36
07/26/17
16:36
Earnings
CoStar Group reports Q2 EPS 86c, consensus 63c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 14

    Aug

  • 15

    Aug

TBK

Triumph Bancorp

$28.80

0.2 (0.70%)

16:35
07/26/17
07/26
16:35
07/26/17
16:35
Conference/Events
Triumph Bancorp to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 18

    Sep

ORLY

O'Reilly Automotive

$187.43

0.58 (0.31%)

16:35
07/26/17
07/26
16:35
07/26/17
16:35
Earnings
O'Reilly Automotive reports Q2 EPS $3.10, consensus $2.89 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

ASGN

On Assignment

$51.71

-1.57 (-2.95%)

16:35
07/26/17
07/26
16:35
07/26/17
16:35
Earnings
On Assignment sees Q3 adjusted EPS 73c-76c, consensus 80c »

Sees Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

CNO

CNO Financial

$21.75

-0.52 (-2.34%)

16:35
07/26/17
07/26
16:35
07/26/17
16:35
Earnings
CNO Financial reports Q2 EPS 48c, consensus 37c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

BWLD

Buffalo Wild Wings

$122.65

-1.05 (-0.85%)

16:35
07/26/17
07/26
16:35
07/26/17
16:35
Hot Stocks
Breaking Hot Stocks news story on Buffalo Wild Wings »

Buffalo Wild Wings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 16

    Aug

  • 11

    Sep

WHR

Whirlpool

$190.19

-0.76 (-0.40%)

16:34
07/26/17
07/26
16:34
07/26/17
16:34
Hot Stocks
Whirlpool increases share repurchase authorization to $2.35B »

"Our strong free…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DRE

Duke Realty

$28.42

0.69 (2.49%)

16:34
07/26/17
07/26
16:34
07/26/17
16:34
Earnings
Breaking Earnings news story on Duke Realty »

Duke Realty sees 2017…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

BXS

BancorpSouth

$30.25

-1 (-3.20%)

16:33
07/26/17
07/26
16:33
07/26/17
16:33
Hot Stocks
BancorpSouth raises quarterly dividend 12% to 14c per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 18

    Sep

DRE

Duke Realty

$28.42

0.69 (2.49%)

16:33
07/26/17
07/26
16:33
07/26/17
16:33
Earnings
Duke Realty reports Q2 core FFO 32c, consensus 31c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

ASGN

On Assignment

$51.71

-1.57 (-2.95%)

16:33
07/26/17
07/26
16:33
07/26/17
16:33
Earnings
On Assignment reports Q2 EPS 62c, consensus 72c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

ANIK

Anika Therapeutics

$47.99

-0.27 (-0.56%)

16:33
07/26/17
07/26
16:33
07/26/17
16:33
Earnings
Anika Therapeutics reports Q2 EPS 76c, consensus 44c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

UVSP

Univest

$30.00

-0.3 (-0.99%)

16:33
07/26/17
07/26
16:33
07/26/17
16:33
Earnings
Breaking Earnings news story on Univest »

Univest reports Q2 EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 01

    Aug

O

Realty Income

$57.92

0.49 (0.85%)

16:33
07/26/17
07/26
16:33
07/26/17
16:33
Hot Stocks
Realty Income sees FY17 EPS $1.15-$1.20, consensus $1.22 »

Company estimates FY17…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

WHR

Whirlpool

$190.19

-0.76 (-0.40%)

16:33
07/26/17
07/26
16:33
07/26/17
16:33
Earnings
Whirlpool reports Q2 EPS $3.35, consensus $3.54 »

Reports Q2 revenue $5.3B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMO

Capstead Mortgage

$9.99

-0.06 (-0.60%)

16:32
07/26/17
07/26
16:32
07/26/17
16:32
Earnings
Capstead Mortgage reports Q2 EPS 14c, consensus 20c »

Book value per common…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

BPI

Bridgepoint Education

$12.29

-0.98 (-7.39%)

16:32
07/26/17
07/26
16:32
07/26/17
16:32
Earnings
Bridgepoint Education reports Q2 EPS 21c, consensus 23c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 10

    Aug

BDGE

Bridge Bancorp

$32.90

-0.7 (-2.08%)

16:32
07/26/17
07/26
16:32
07/26/17
16:32
Earnings
Breaking Earnings news story on Bridge Bancorp »

Bridge Bancorp reports Q2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

QEP

QEP Resources

$9.27

0.07 (0.76%)

16:31
07/26/17
07/26
16:31
07/26/17
16:31
Earnings
QEP Resources reports Q2 adjusted EPS (12c), consensus (20c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 14

    Aug

MPWR

Monolithic Power

$106.79

1.86 (1.77%)

16:31
07/26/17
07/26
16:31
07/26/17
16:31
Earnings
Breaking Earnings news story on Monolithic Power »

Monolithic Power sees Q3…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 08

    Aug

  • 10

    Aug

  • 15

    Aug

UDR

UDR, Inc.

$39.19

0.51 (1.32%)

16:31
07/26/17
07/26
16:31
07/26/17
16:31
Earnings
UDR, Inc. backs FY17 EPS view of 31c-36c, consensus 28c »

Reaffirmed FFO per share…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

FFIV

F5 Networks

$128.20

0.18 (0.14%)

16:30
07/26/17
07/26
16:30
07/26/17
16:30
Earnings
F5 Networks sees Q4 non-GAAP EPS $2.20-$2.23, consensus $2.24 »

Sees Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 05

    Sep

MPWR

Monolithic Power

$106.79

1.86 (1.77%)

16:30
07/26/17
07/26
16:30
07/26/17
16:30
Earnings
Monolithic Power reports Q2 EPS 68c, consensus 67c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 08

    Aug

  • 10

    Aug

  • 15

    Aug

O

Realty Income

$57.92

0.49 (0.85%)

16:30
07/26/17
07/26
16:30
07/26/17
16:30
Earnings
Realty Income reports Q2 EPS 30c, consensus 32c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

FMNB

Farmers National Banc

$14.35

-0.4 (-2.71%)

16:30
07/26/17
07/26
16:30
07/26/17
16:30
Earnings
Farmers National Banc reports Q2 EPS 21c, consensus 22c »

Total loans were $1.51…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.